VP, Global Immuno-Oncology Clinical Development

Kaye/Bassman International; Boston (MA); On-site; USD 300,000 - 520,000; Full time

Job summary

Kaye/Bassman International is partnering with a clinical-stage immuno-oncology biotech to search for a Vice President, Clinical Development in the Boston area. The leader will set strategic clinical direction for global oncology programs, focusing on next-generation checkpoint inhibitor combinations advancing into registrational Phase 3 in gastrointestinal tumors.

This senior role combines strategic oversight with hands-on medical monitoring, data review, and cross-functional leadership across

Qualifications

• MD degree or international equivalent with oncology/biotech expertise.
• 8+ years in biotech/pharma clinical development, with sponsor-side oncology experience.
• Experience leading programs from design through Phase 3 and regulatory submissions.
• Immuno-oncology experience with checkpoint inhibitors preferred.
• Strong leadership, communication, and ability to influence at senior leadership level.

Responsibilities

• Lead clinical development strategy across early- to registrational programs.
• Translate efficacy, safety, biomarker data into development decisions.
• Provide clinical leadership for Phase 3 execution and regulatory submissions.
• Serve as Medical Monitor for trials and oversee safety surveillance.
• Lead data review with Clinical Operations, Data Management, Biostatistics.
• Author protocols, investigator brochures, clinical study reports, and regulatory sections.
• Represent Clinical Development with senior leadership, KOLs, investigators, and health authorities.
• Present to DSMBs, steering committees, and support abstracts.
• Mentor the Clinical Development team and partner cross-functionally.

Skills

Strategic leadership

Clinical development strategy

Oncology drug development

Cross-functional leadership

Regulatory submissions

Education

MD or international equivalent

Job description

Kaye/Bassman International is partnering with a clinical-stage immuno-oncology biotech to search for a Vice President, Clinical Development in the Boston area. The leader will set strategic clinical direction for global oncology programs, focusing on next-generation checkpoint inhibitor combinations advancing into registrational Phase 3 in gastrointestinal tumors.

This senior role combines strategic oversight with hands-on medical monitoring, data review, and cross-functional leadership across